Summary
Introduction The challenges related to the prevention, diagnosis, and treatment of cardiovascular diseases remain acute. One of the measures to prevent these conditions from occurring is early detection of risk factors, one of which is coronary calcium. The latest achievements in computer vision made it possible to conduct opportunistic screening for coronary calcium.
Objective To study the prevalence of coronary artery calcification (CAC) as a risk factor for cardiovascular diseases in the Moscow population based on automated analysis of imaging findings.
Materials and methods A retrospective descriptive epidemiology study was carried out. Chest CT studies of 165,234 patients were analyzed. AI services carried out the automated analysis to detect CAC and to calculate the CAC score (CACS).
Results Coronary calcium was detected in 61.4% of the participants. The proportion of diagnosed men was 68.9% (of all men), women – 55.7% (of all women) (p<0.001). The CAC score ranged between 1 to 60,306; the mean value was 558.2. The mean CACS increase for the entire population was 170.75; the mean growth was 168.13% the mean growth rate was 68.13%. 47.6% of men and 36.5% of women had clinically significant CACS (p<0.001). Most participants with clinically significant CAC belonged to Elderly and Senile age groups (42.0% each).
Conclusions The prevalence of coronary calcium in the Moscow population was 8.03 per 1000 people. CAC (including clinically significant) was significantly more common in men. The mean CACS was significantly higher compared to the female population across most age groups. There is a continuous increase in the mean CACS with age.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This paper was prepared by a group of authors as a part of the research and development effort titled "Evidence-based methodologies for sustainable development of artificial intelligence in medical imaging", registration number to EGISU: 123031500004-5.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Independent Ethics Committee of Moscow Regional Office of the Russian Society of Radiologists and Radiographists gave ethical approval for this work (extract from the protocol N 2 dated February 20, 2020). This study is registered on ClinicalTrials (NCT04489992).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Contact author: e-mail: VladzimirskijAV{at}zdrav.mos.ru
To our great regret, in the original version of the manuscript, the names of the development companies were indicated inaccurately. Names of these development companies clarified
Data Availability
All data produced in the present work are contained in the manuscript
